These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12637036)
1. Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression. Angelucci F; Aloe L; Jiménez-Vasquez P; Mathé AA Neuropeptides; 2003 Feb; 37(1):51-6. PubMed ID: 12637036 [TBL] [Abstract][Full Text] [Related]
2. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Angelucci F; Mathé AA; Aloe L Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963 [TBL] [Abstract][Full Text] [Related]
3. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Angelucci F; Aloe L; Jiménez-Vasquez P; Mathé AA Int J Neuropsychopharmacol; 2003 Sep; 6(3):225-31. PubMed ID: 12974988 [TBL] [Abstract][Full Text] [Related]
4. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Angelucci F; Aloe L; Vasquez PJ; Mathé AA Neuroreport; 2000 Apr; 11(6):1369-73. PubMed ID: 10817624 [TBL] [Abstract][Full Text] [Related]
5. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. Angelucci F; Aloe L; Jiménez-Vasquez P; Mathé AA J ECT; 2002 Sep; 18(3):138-43. PubMed ID: 12394532 [TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Jiménez Vasquez PA; Salmi P; Ahlenius S; Mathé AA Behav Brain Res; 2000 Jun; 111(1-2):115-23. PubMed ID: 10840138 [TBL] [Abstract][Full Text] [Related]
7. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Elfving B; Plougmann PH; Müller HK; Mathé AA; Rosenberg R; Wegener G Int J Neuropsychopharmacol; 2010 Jun; 13(5):563-72. PubMed ID: 19796445 [TBL] [Abstract][Full Text] [Related]
8. Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli. Hvilsom AST; Lillethorup TP; Iversen P; Doudet DJ; Wegener G; Landau AM Eur Neuropsychopharmacol; 2019 Apr; 29(4):493-500. PubMed ID: 30826156 [TBL] [Abstract][Full Text] [Related]
9. Effects of repeated minimal electroshock seizures on NGF, BDNF and FGF-2 protein in the rat brain during postnatal development. Kim J; Gale K; Kondratyev A Int J Dev Neurosci; 2010 May; 28(3):227-32. PubMed ID: 20170723 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli. Jiménez-Vasquez PA; Overstreet DH; Mathé AA J Psychiatr Res; 2000; 34(6):405-12. PubMed ID: 11165308 [TBL] [Abstract][Full Text] [Related]
11. Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain. Angelucci F; Aloe L; Iannitelli A; Gruber SH; Mathé AA Eur Neuropsychopharmacol; 2005 May; 15(3):311-7. PubMed ID: 15820421 [TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depression. Lillethorup TP; Iversen P; Fontain J; Wegener G; Doudet DJ; Landau AM Eur Neuropsychopharmacol; 2015 Mar; 25(3):404-12. PubMed ID: 25604421 [TBL] [Abstract][Full Text] [Related]
13. Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Katoh-Semba R; Semba R; Takeuchi IK; Kato K Neurosci Res; 1998 Jul; 31(3):227-34. PubMed ID: 9809668 [TBL] [Abstract][Full Text] [Related]
14. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Hock C; Heese K; Hulette C; Rosenberg C; Otten U Arch Neurol; 2000 Jun; 57(6):846-51. PubMed ID: 10867782 [TBL] [Abstract][Full Text] [Related]
15. The antidepressant effect of running is associated with increased hippocampal cell proliferation. Bjørnebekk A; Mathé AA; Brené S Int J Neuropsychopharmacol; 2005 Sep; 8(3):357-68. PubMed ID: 15769301 [TBL] [Abstract][Full Text] [Related]
16. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Altar CA; Whitehead RE; Chen R; Wörtwein G; Madsen TM Biol Psychiatry; 2003 Oct; 54(7):703-9. PubMed ID: 14512210 [TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Jiménez-Vasquez PA; Diaz-Cabiale Z; Caberlotto L; Bellido I; Overstreet D; Fuxe K; Mathé AA Eur Neuropsychopharmacol; 2007 Mar; 17(4):298-308. PubMed ID: 16904299 [TBL] [Abstract][Full Text] [Related]
18. Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Woodhall E; West AK; Chuah MI Brain Res Mol Brain Res; 2001 Mar; 88(1-2):203-13. PubMed ID: 11295250 [TBL] [Abstract][Full Text] [Related]
19. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008 [TBL] [Abstract][Full Text] [Related]
20. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder. Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]